A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells

被引:0
|
作者
Eva Andersson
Paula Henderikx
Elias Krambovitis
Hennie R. Hoogenboom
Carl A. K. Borrebaeck
机构
[1] Department of Immunotechnology,
[2] Lund University,undefined
[3] P.O. Box 7031,undefined
[4] S-220 07 Lund,undefined
[5] Sweden e-mail: carl.borrebaeck@immun.lth.se Fax: +46-46-222 4200,undefined
[6] CESAME,undefined
[7] Department of Pathology,undefined
[8] University Hospital and Maastricht University,undefined
[9] Maastricht,undefined
[10] The Netherlands,undefined
[11] Laboratory of Applied Biochemistry and Immunology,undefined
[12] Institute of Molecular Biology and Biotechnology,undefined
[13] Heraklion,undefined
[14] Greece,undefined
来源
关键词
Key words In vitro immunisation; MUC1; Human; antibodies; Phage display; Carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
We have recently described an efficient method to study the human humoral immune response in vitro and to generate isotype-switched, antigen-specific human B cells, which has allowed us to produce high-affinity IgG antibodies against different peptides. In an attempt to study the in vitro immune response against self-antigens, such as tumour-associated antigens, this protocol was used to immunise resting human peripheral blood B cells with a peptide epitope from the human-adenocarcinoma-associated antigen, MUC1. After the two-step in vitro immunisation, the secondary immunised cultures were tested for MUC-1-specific antibodies by enzyme-linked immunosorbent assay (ELISA). Phage molecular libraries were subsequently constructed, using the variable parts of Ig genes derived from cells taken from ELISA-positive wells. The libraries were selected on the MUC1 core peptide. Antigen-specific Fab fragments, specific for the self antigen MUC1, were found in the library of secondary immunised IgG+ B cells and these antibodies were evaluated by BIAcore analysis. The specific Fab fragments exhibited an unusually rapid dissociation rate constant and the overall response frequency was lower, as compared to other antibodies generated by this protocol, which might be explained by the repetitive nature of the core peptide used for immunisation.
引用
收藏
页码:249 / 256
页数:7
相关论文
共 50 条
  • [1] A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells
    Andersson, E
    Henderikx, P
    Krambovitis, E
    Hoogenboom, HR
    Borrebaeck, CAK
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 47 (05) : 249 - 256
  • [2] Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1
    Correa, I
    Plunkett, T
    Coleman, J
    Galani, E
    Windmill, E
    Burchell, JM
    Taylor-Papdimitriou, J
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (05) : 760 - 768
  • [3] Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women
    Croce, MV
    Isla-Larrain, MT
    Capafons, A
    Price, MR
    Segal-Eiras, A
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 1 - 11
  • [4] Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core
    Kinarsky, L
    Suryanarayanan, G
    Prakash, O
    Paulsen, H
    Clausen, H
    Hanisch, FG
    Hollingsworth, MA
    Sherman, S
    GLYCOBIOLOGY, 2003, 13 (12) : 929 - 939
  • [5] Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women*
    María V. Croce
    Marina T. Isla-Larrain
    Adriana Capafons
    Mike R. Price
    Amada Segal-Eiras
    Breast Cancer Research and Treatment, 2001, 69 : 1 - 11
  • [6] Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation
    Agrawal, B
    Krantz, MJ
    Parker, J
    Longenecker, BM
    CANCER RESEARCH, 1998, 58 (18) : 4079 - 4081
  • [7] MURINE IMMUNE-RESPONSE TO CELLS TRANSFECTED WITH HUMAN MUC1 - IMMUNIZATION WITH CELLULAR AND SYNTHETIC ANTIGENS
    APOSTOLOPOULOS, V
    XING, PX
    MCKENZIE, IFC
    CANCER RESEARCH, 1994, 54 (19) : 5186 - 5193
  • [8] Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
    Snijdewint, FGM
    von Mensdorff-Pouilly, S
    Karuntu-Wanamarta, AH
    Verstraeten, AA
    van Zanten-Przybysz, I
    Hummel, P
    Nijman, HW
    Kenemans, P
    Hilgers, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (01) : 47 - 55
  • [9] Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
    F. G. M. Snijdewint
    S. von Mensdorff-Pouilly
    A. H. Karuntu-Wanamarta
    A. A. Verstraeten
    I. van Zanten-Przybysz
    P. Hummel
    H. W. Nijman
    P. Kenemans
    J. Hilgers
    Cancer Immunology, Immunotherapy, 1999, 48 : 47 - 55
  • [10] Immunotoxins against a non-tandem repeat epitope on the membrane bound MUC1 kill tumor cells
    Karmely, Maya
    Rubinstein, Daniel B.
    Wreschner, Daniel H.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3612S - 3613S